Medisponge

Trade name

Medisponge

08904085093136

B-08904085093136

Reference / catalog number

MSES 1014

GS1

Class III

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

Sterile Haemostatic Absorbable Gelatin Sponge - IP/USP is a hemostatic absorbable medical device manufactured from highly purified neutral gelatin material of porcine origin. It is a white, light white or almost white water-insoluble, highly porous, pliable product intended for application to bleeding surfaces as a hemostat during surgical procedures when use of conventional bleeding control procedures are ineffective, difficult to apply or impractical. The uniform porosity of MEDISPONGE® enables the fluid volume to hold on the bleeding site and creates a physical pressure resulting in an accelerated hemostasis. It adheres well to the bleeding site and can absorb blood or body fluids not less than 35 times of its own weight and assists in achieving hemostasis in 3 to 6 minutes. Sterile Haemostatic Absorbable Gelatin Sponge - USP/IP is biocompatible as per applicable EN ISO 10993 standards. Sterile Haemostatic Absorbable Gelatin sponge - USP/IP is manufactured in different physical formats and/or shapes to suit the needs of surgeons for application for an effective hemostasis in different types of surgeries.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 125x80x10 mm

European Medical Device Nomenclature — the EU product classification assigned to this device.

• M040503GELATINE SPONGE HAEMOSTATIC DRESSINGS

3 warnings recorded — scroll inside the panel to see all entries.

• CONTRAINDICATIONS: Sterile Haemostatic Absorbable Gelatin Sponge – IP/USP should not be used during the surgical closure of skin incisions because it may interfere with the healing of skin edges. This is due to mechanical interposition of gelatin and is not secondary to intrinsic interference with wound healing. Do not use Sterile Haemostatic Absorbable Gelatin Sponge – IP/USP in patients with known allergies to gelatin or gelatin derived products.

  OTHER

• PRECAUTIONS & WARNINGS: • Product for use by Registered Medical Practitioner or a Hospital or a Laboratory. • This product is not designed, sold or intended for use except as indicated. Keep out of reach of children. • MEDISPONGE® is to be used as an adjunct and is not intended to be substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis. • To prevent contamination, employ aseptic procedure in opening envelope and withdrawing MEDISPONGE®. If the package is torn or punctured, the contained MEDISPONGE® should not be used. • The use of MEDISPONGE® is not recommended in the presence of infection. MEDISPONGE® should be used with caution in contaminated areas of the body. • Once hemostasis is achieved any excess MEDISPONGE® should be carefully removed to prevent the possibility of dislodgment of the device or compression of other nearby anatomic structures.

  OTHER

• • MEDISPONGE® should be removed from the site of application when used in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord and/or the optic nerve and chiasm. This is because MEDISPONGE® may swell to its original size on absorbing fluids, and produce nerve damage by pressure within confined bony spaces. This may interfere with normal function and/or possibly result in compression necrosis of surrounding tissues. • MEDISPONGE® should not be used for the primary treatment of coagulation disorders. • MEDISPONGE® should not be used for controlling post-partum intrauterine bleeding or menorrhagia. • Upon application, if signs of irritation (redness), maceration (whitening of surrounding skin) or itching develop, remove and discontinue use of MEDISPONGE® and consult a healthcare professional. • In case MEDISPONGE® is left at the bleeding site and signs of infection such as fever, increased pain, bleeding, swelling, unusual odour, cloudy or foul drainage or abscess develop at the site, remove the infected material and consult a healthcare professional immediately. • Although the safety and effectiveness of the combined use of MEDISPONGE® with other agents such as topical thrombin, antibiotic solution or antibiotic powder has not been evaluated in controlled clinical trials, if in the physician's judgment, concurrent use of topical thrombin or other agents is medically advisable, the product literature for that agent should be consulted for complete prescribing information.